Abstract

Results 311 new patients were observed (305 HIV-1 infected and 6 HIV-2 infected), with a mean age of 42 ± 13,7 years. 218 (70%) patients were men. Risk factor for HIV-infection was sexual in 271 (87%) patients (18% were homo-bisexual). At the time of diagnosis the mean CD4+ cell count was 333 ± 305 cells/mm3; 132 (42,4%) patients had CD4 cell count <200/mm. In 89 (28,6%) patients an AIDS-defining illness was diagnosed simultaneously with HIV-infection diagnosis; 43% of these were tuberculosis. After a mean follow-up of 15 ± 9,7 months 27 (8,6%) patients died, 24/27 (88,8%) with AIDS and the other 3 patients one each with eosophageal cancer, hepatic failure and MSSA sepsis,. In 22/27 (81,4%) of the deceased patients the CD4 cell count was <200 cells/mm at the time of the HIV diagnosis. Discussion In the last 3 years, 42% of the new diagnosed patients had a serious immunological deficit. In 28% of them HIV-infection was diagnosed simultaneously with a defining AIDS opportunistic infection. The fact that 81,4% of the deceased patients had a CD4 cell count <200/mm at diagnosis shows that HIV-infection diagnosis was done too late for ART to be of benefit.

Highlights

  • Current guidelines of antiretroviral therapy (ART) recommend starting ART before an advanced immunological deterioration

  • The benefit of early ART is lost when diagnosis is established at an advanced stage of the disease

  • The aim of this study is to evaluate the clinical and immunological data at the first observation of HIV-infected patients in an Infectious Diseases Service

Read more

Summary

Open Access

Clinical and immunological presentation of new HIV-infected patients in an outpatient clinic. From 16th International Symposium on HIV and Emerging Infectious Diseases Marseille, France. From 16th International Symposium on HIV and Emerging Infectious Diseases Marseille, France. 24-26 March 2010

Background
Discussion
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.